Veerhealth Care on Monday said it is expecting to reach revenue of Rs 100 crore in the next 2 to 3 years.

Veerhealth Care expects Rs 100 crore revenue in upcoming 2-3 years

Veerhealth Care announced that the company has executed & delivered export order valued at US$ 50,000 (approximately Rs 41.50 lakhs), another export order valued at $ 197,793 (approximately Rs 1.65 crore) which shall be fully executed and delivered by end of July.

Veerhealth Care secures new export order of Rs 89 lakh

Here are the buzzings stocks for the day: Tata Coffee, 3i Infotech, Crisis, ICICI Lombard GIC, Kilburn Engineering, Jubilant Foodworks, Quick Heal tech, Taylormade Renewables, Flexituff, Veerhealth Care, Accelya Solutions

Stocks that will see action today: April 18, 2023

Veerhealth Care Standalone December 2020 Net Sales At Rs 3.85 Crore, Up 72.7% Y-o-Y

Veerhealth Care standalone net profit declines 44.44% in the December 2020 quarter

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Veerhealth Care is engaged in manufacturing and marketing research-based Ayurvedic medicines. The Company's product categories include Tablets, Syrups, Ointments, Powder, Oil and Toothpaste.